VAAST pipeline

VAAST specifications


Unique identifier OMICS_02134
Alternative name Variant Annotation, Analysis and Search Tool
Software type Package/Module
Interface Command line interface
Restrictions to use Academic or non-commercial use
Operating system Unix/Linux
Computer skills Advanced
Version 2.0
Stability Stable
Maintained Yes


  • Primates
    • Homo sapiens


  • pVAAST


Add your version



  • person_outline Mark Yandell <>

Additional information

A registration is needed to access to tools.

Publications for Variant Annotation, Analysis and Search Tool

VAAST IN pipeline

PMCID: 5030307
PMID: 27708560
DOI: 10.3389/fnins.2016.00428

[…] and were all predicted to be deleterious by mutationtaster functional prediction algorithm (schwarz et al., 2010; table s2). one confirmed slitrk1 variant (rs146746846) was also identified by vaast under a recessive model of inheritance (table s3). proxy ld snps available for rs150504822 on slitrk1 were input into ldookup to identify significant variants in other gwas studies. a variant […]

VAAST institution(s)
Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA; Institute for Systems Biology, Seattle, WA, USA; Department of Psychiatry, University of Utah, Salt Lake City, UT, USA; Department of Pediatrics, University of Utah, Salt Lake City, UT, USA; Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT, USA; ARUP Institute for Clinical and Experimental Pathology, ARUP Laboratories, Salt Lake City, UT, USA; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA; Department of Human Genetics and USTAR Center for Genetic Discovery, University of Utah, Salt Lake City, UT, USA; Department of Genetics, Rutgers, the State University of New Jersey, Piscataway, NJ, USA; Department of Pediatrics, The Ohio State University, Columbus, OH, USA; Center for Cardiovascular and Pulmonary Research, Research Institute at Nationwide Children’s Hospital, Columbus, OH, USA; Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg; Pacific Northwest Diabetes Research Institute, Seattle, WA, USA; Gladstone Institute of Cardiovascular Disease and University of California, San Francisco, San Francisco, CA, USA; Omicia, Inc., Oakland, CA, USA
VAAST funding source(s)
Supported by US National Institutes of Health grants R01 GM104390, R01 DK091374, R01 CA164138, R44HG006579 and R01 GM59290, the University of Luxembourg—Institute for Systems Biology Program, grants from the NHLBI (UO1 HL100406 and U01 HL098179), NIH grants R01 MH094400 and R01 MH099134, the MD Anderson Cancer Center Odyssey Program and NIH grant R00HG005846.

VAAST reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review VAAST